검색
IDEAYA Biosciences Inc
IDYA관심 목록에 추가
35.500USD
-0.900-2.47%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
3.38B시가총액
손실P/E TTM
자세한 내용은 IDEAYA Biosciences Inc 회사
IDEAYA Biosciences, Inc. is a precision medicine oncology company. The Company is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 / GSK959 (Werner Helicase), IDE161 (PARG), and IDE705 / GSK101 (Pol Theta Helicase). IDE196, a small-molecule protein kinase C (PKC) inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397 is its small-molecule methionine adenosyltransferase 2a (MAT2A) inhibitor. IDE275 (GSK959) Werner Helicase (WRN) inhibitor for patients having tumors with MSI-High. IDE161 (PARG) is a small-molecule poly (ADP-ribose) glycohydrolase, or PARG, inhibitor. IDE705 is a small-molecule inhibitor of Pol Theta Helicase, in combination with niraparib, the GSK small-molecule inhibitor of poly-(ADP-ribose) polymerase (PARP).
IDEAYA Biosciences Inc 정보
종목 코드 IDYA
회사 이름IDEAYA Biosciences Inc
상장일May 23, 2019
CEOHata (Yujiro S)
직원 수131
유형Ordinary Share
회계 연도 종료May 23
주소7000 Shoreline Ct, Suite 350
도시SOUTH SAN FRANCISCO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94080
전화16504436209
웹사이트https://www.ideayabio.com/
종목 코드 IDYA
상장일May 23, 2019
CEOHata (Yujiro S)
IDEAYA Biosciences Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Yujiro S. Hata
Mr. Yujiro S. Hata
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Andres Ruiz Briseno, CPA
Mr. Andres Ruiz Briseno, CPA
Chief Accounting Officer, Senior Vice President, Head - Finance and Investor Relations
Chief Accounting Officer, Senior Vice President, Head - Finance and Investor Relations
--
--
Ms. Wendy L. Yarno
Ms. Wendy L. Yarno
Independent Director
Independent Director
--
--
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Independent Director
--
--
Dr. Terry J. Rosen, Ph.D.
Dr. Terry J. Rosen, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
Independent Director
Independent Director
--
--
Dr. M. Garret Hampton, Ph.D.
Dr. M. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Catherine J. Mackey, Ph.D.
Dr. Catherine J. Mackey, Ph.D.
Independent Director
Independent Director
--
--
Dr. Michael A. White, Ph.D.
Dr. Michael A. White, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Darrin Beaupre, M.D., Ph.D.
Dr. Darrin Beaupre, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Yujiro S. Hata
Mr. Yujiro S. Hata
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Andres Ruiz Briseno, CPA
Mr. Andres Ruiz Briseno, CPA
Chief Accounting Officer, Senior Vice President, Head - Finance and Investor Relations
Chief Accounting Officer, Senior Vice President, Head - Finance and Investor Relations
--
--
Ms. Wendy L. Yarno
Ms. Wendy L. Yarno
Independent Director
Independent Director
--
--
Mr. Scott W. Morrison, CPA
Mr. Scott W. Morrison, CPA
Independent Director
Independent Director
--
--
Dr. Terry J. Rosen, Ph.D.
Dr. Terry J. Rosen, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
Independent Director
Independent Director
--
--
자주 묻는 질문
IDEAYA Biosciences Inc의 상위 5대 주주는 누구인가요?
IDEAYA Biosciences Inc의 상위 5대 주주는 다음과 같습니다: Mr. Yujiro S. Hata
IDEAYA Biosciences Inc(IDYA)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, IDEAYA Biosciences Inc의 주식을 보유한 기관은 총 518곳이며, 이들이 보유한 주식의 총 가치는 약 97.55M로 전체 발행 주식의 111.03%를 차지합니다. 이는 2025Q4 대비 -12932948.00 증가한 수치입니다.